Skip to Content

Clinically and statistically significant improvement for efgartigimod in adults with ITP

In this MEDtalk dr. Catherine, Broome, associate, professor of Medicine at Med.Star Georgetown University Hospital in Washington, present the data of efficacy and safety for intravenous efgartigimod in adults with primary immune thrombocytopenia from the ADVANCE IV study, a multi-center double-blinded placebo controlled randomized clinical trial.

Catherine Broome

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top